Determination of rubella virus-specific cell-mediated immunity using IFNγ-ELISpot

Journal of Medical Virology

Volumn 82, Issue 2, 2010, Pages 335-340

  Allmendinger, J ^a   Paradies, F ^a   Kamprad, M ^a   Richter, T ^a   Pustowoit, B ^a   Liebert, U G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cell mediated immunity; ELISpot; Rubella virus

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; RUBELLA VACCINE; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS 77; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RUBELLA; RUBELLA VIRUS; VIRUS DETECTION; VIRUS LIKE AGENT; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELLS, CULTURED; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOASSAY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; RUBELLA VIRUS; VIROSOMES; YOUNG ADULT;

RUBELLA; RUBELLA VIRUS;

EID: 74549139043     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21621     Document Type: Article

References (35)

1. Aguilar P, Renoult E, Jarrosson L, Kolopp-Sarda MN, Mathieu CP, Faure GC, Kesser M, BeneMC, Kohler C, KennelDeMarch A. 2003. Anti-HBs cellular immune response in kidney recipients before and 4months after transplantation. Clin Diagn Lab Immunol 10:1117-1122.
2. Al SherbinyM,Osman A, MohamedN, Shata MT, Abdel-Aziz F, Abdel-HamidM, et al. 2005. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 73:44-49.
3. Altfeld MA, Trocha A, Eldridge RL, Rosenberg ES, Phillips MN, Addo MM, Sekewly RP, Kalams SQ, Burchett SA, cIntosh K, Walker BD, Goulder PJ. 2000. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: Rapid characterization of CTL responses by enzymelinked immunospot assay. J Virol 74:8541-8549.
4. Best JM. 1991. Rubella vaccines: Past, present and future. Epidemiol Infect 107:17-30.
5. Brody JA. 1966. The infectiousness of rubella and the possibility of reinfection. Am J Public Health Nations Health 56:1082-1087.
6. Buimovici-Klein E, Cooper LZ. 1985. Cell-mediated immune response in rubella infections. Rev Infect Dis 7:S123-S128.
7. Chantler JK, Tingle AJ, Petty RE. 1985. Persistent rubella virus infection associated with chronic arthritis in children.NEngl JMed 313:1117-1123.
8. Chaye HH, Mauracher CA, Tingle AJ, Gillam S. 1992. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C. J Clin Microbiol 30:2323-2329.
9. Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH. 2002. A panel ofMHCclass I restricted viral peptides for use as a quality control for vaccine trial ELISpot assays. J Immunol Methods 260:157-172.
10. Deng Y, Jing Y, Campbell AE, Gravenstein S. 2004. Age-related impaired type 1 T cell responses to influenza: Reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172:3437-3446.
11. Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA. 2005. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clin Immunol 115:154-161.
12. Ehlers S, Smith KA. 1991. Differentiation of T cell lymphokine gene expression: The in vitro acquisition of T cell memory. J Exp Med 173:25-36.
13. Gans HA, Yasukawa LL, Alderson A, Rinki M, Dehovitz R, Beeler J, Audet S, Maldonado Y, ArvinAM. 2004. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis 190:83-90.
14. Godard B, Gazagne A, Gey A, Baptiste M, Vingert B, Pegaz-Fiornet B, Strompf L, Fridman WH, Glotz D, Tartour E. 2004. Optimization of an ELISpot assay to detect cytomegalovirus-specific CD8+ T lymphocytes. Hum Immunol 65:1307-1318.
15. Helms T, Boehm BO, Asaad RJ, Trezza RP, Lehmann PV, Tary-Lehmann M. 2000. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J Immunol 164:3723-3732.
16. Hobeika AC, Morse MA, Osada T, Ghanayem M, Niedzwiecki D, Barrier R, Lyerly HK, Clay TM. 2005. Enumerating antigenspecific T-cell responses in peripheral blood: A comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis. J Immunother 28:63-72.
17. Hobman TC, Lundstrom ML, Mauracher CA, Woodward L, Gillam S, Farquhar MG. 1994. Assembly of rubella virus structural proteins into virus-like particles in transfected cells. Virology 202:574-585.
18. Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, Varma A, Deeks SG, McCane JM, Nixon DF, Sinclair E. 2003. Comparison of the ELISpot and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods 283:141-153.
19. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. 1997. Rapid effector function in CD8+ memory T cells. J Exp Med 186:859-865.
20. Larsson M, JinX, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ,Cox WI, Steinman RM, Nixoin D, Bhardwaj N. 1999. A recombinant vaccinia virus based ELISpot assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13:767-777.
21. Lindemann M, Witzke O, Lutkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M. 2006. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol 120:342-348.
22. Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA. 2003. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol 10:411-416.
23. Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, Poland GA. 2007. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 14:115-122.
24. Paul WE, Seder RA. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
25. Plotkin SA, Reef S. 2004. Rubella vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines, 4th edition. Philadelphia: E.B. Saunders Company. pp 409-439.
26. Post JJ,Pan Y, Freeman AJ, Harvey CE, White PA, Palladinetti P, et al. 2004. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 189:1846-1855.
27. Pustowoit B, Liebert UG. 1998. Predictive value of serological tests in rubella virus infection during pregnancy. Intervirology 41:170-177.
28. Pustowoit B, Grangeot-Keros L, Hobman TC, Hofmann J. 1996. Evaluation of recombinant rubella-like particles in a commercial immunoassay for the detection of anti-rubella IgG. Clin Diagn Virol 5:13-20.
29. Samri A, Durier C, Urrutia A, Sanchez I, Gahery-Segard H, Imbart S, Sinet M, Tartour E, Aboulker JP, Autran B, Venet A. 2006. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 13:684-697.
30. Scheibenbogen C,Romero P, RivoltiniL,HerrW,Schmittel A, Cerottini JC, et al. 2000. Quantitation of antigen-reactive T cells in peripheral blood by IFNg-ELISpot assay and chromium-release assay: A four-centre comparative trial. J Immunol Methods 244:81-89.
31. Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ. 2001. Development and validation of a gamma Interferon ELISPOT assay for quantitation of cellular immune responses to Varicella-Zoster virus. Clin Diagn Lab Immunol 5:871-879.
32. Smith JG, Joseph HR, Green T, Field JA, Wooters M, Kaufhold RM, Antonello J, Caulfield MJ. 2007. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin Vaccine Immunol 14:527-537.
33. Sprent J. 1997. Immunological memory. Curr Opin Immunol 9:371-379.
34. Toyoda M, Ihara T, Nakano T, Ito M, Kamiya H. 1999. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccines. Vaccine 17:2051-2058.
35. WardBJ, Boulianne N, Ratnam S, Guiot MC, CouillardM,De Serres G. 1995. Cellular immunity in measles vaccine failure: Demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 172:1591-1595.